GSK3B and neoplasm: Consistent with a potential role as a tumor suppressor and in line with recent publications from our lab, it has been experimentally shown [102] that the N-terminal SCAN domain of Peg3 mediated direct binding to β-catenin and promotes 26S proteasomal degradation that is, surprisingly, independent of GSK3β.